Bashar Staitieh is a Respiratory physician affiliated with Grady Memorial Hospital. OpenAlex indexes 66 publications with 1,511 citations (h-index 16).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
615 Michael St NE
Suite 211
Atlanta, GA 303221047
Telephone
404-712-8286Registry record last updated 8 Oct 2015.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
88.9%beta2-Adrenergic Agonist54.2%Albuterol Sulfate Hfa63%Ventolin Hfa37%Part D≥22 patientsCorticosteroid11.8%Fluticasone Propionate65%Qvar Redihaler35%Part D<11 patients+ 3 more classes in this area
Metabolism & gastrointestinal
6.9%Corticosteroid6.9%Prednisone100%Part D<11 patientsAnti-infectives
4.2%Macrolide Antimicrobial4.2%Azithromycin100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2017–2026 per NIH RePORTER. The latest:
- Investigating alveolar macrophages in PLWH as targets for HIV persistence, residual inflammation and immune activation
Emory University
FY2026$1,048,990R01AI183455 - Investigating alveolar macrophages in PLWH as targets for HIV persistence, residual inflammation and immune activation
Emory University
FY2025$1,030,790R01AI183455 - Investigating alveolar macrophages in PLWH as targets for HIV persistence, residual inflammation and immune activation
Emory University
FY2024$1,010,290R01AI183455
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Pioglitazone Reverses Alcohol-induced Human Immunodeficiency Virus (HIV) Replication and IL-1β Expression in Alveolar Macrophages
American Journal of Respiratory Cell and Molecular Biology
2025 - HIV alters immunometabolic phenotypes of alveolar macrophages during chronic alcohol consumption 2795
The Journal of Immunology
2025 - Comparable Performance on Waveform Analysis Assessment Between Critical Care Physician Trainees and Advanced Practice Provider (APP) Trainees After a Mechanical Ventilation Educational Initiative
American Journal of Respiratory and Critical Care Medicine
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Diogo Haussen, MD
Grady Memorial Hospital
Jonathan Grossberg
Grady Memorial Hospital
Priyathama Vellanki, MD
Grady Memorial Hospital
Fadi Nahab, MD
Grady Memorial Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”